Omicron Antibodies Could Provide Immunity Against Delta COVID Variant: Study

by PTI - Dec 30, 2021 05:09 PM +05:30 IST
Omicron Antibodies Could Provide Immunity Against Delta COVID Variant: StudyCoronavirus (Representative Image)

Johannesburg, Dec 30 (PTI) Being infected with Omicron may enhance immunity against the Delta variant of coronavirus, suggests a small study by researchers in South Africa.

The Omicron variant of SARS-CoV-2, the virus which causes COVID-19, was first identified in November this year in South Africa and Botswana.

The variant has been shown to be highly transmissible and have extensive evasion of neutralising antibody immunity elicited by vaccination and previous SARS-CoV-2 infection.

Infections from the variant are rapidly expanding worldwide.

The yet-to-be peer-reviewed study, posted on the pre-print repository MedRxiv, enrolled 15 previously vaccinated and unvaccinated people who were infected with the Omicron variant.

The scientists used plasma, a blood product which contains antibodies, from the participants to test the ability of the antibodies to control both Omicron and Delta in the lab -- a so-called 'neutralisation' test.

They measured this close to when the participants had symptoms, and again around two weeks later.

The results show a developing antibody response to Omicron, with neutralisation increasing 14-fold over this time.

However, the team also observed that the participants developed some enhanced immunity against the Delta variant, with Delta neutralisation increasing 4.4-fold.

The researchers also show that vaccinated participants were able to mount a better neutralising response against Delta, while the response in unvaccinated participants was more variable.

'The increase in Delta variant neutralisation in individuals infected with Omicron may result in decreased ability of Delta to re-infect those individuals,' said Professor Alex Sigal, from Africa Health Research Institute.

'If Omicron does prove to be less pathogenic, then this may show that the course of the pandemic has shifted -- Omicron will take over, at least for now, and we may have less disruption of our lives,' Sigal, who led the study, added.

The authors of the study noted that along with emerging data indicating that Omicron, at this time in the pandemic, is less pathogenic than Delta, such an outcome may have positive implications in terms of decreasing the COVID-19 burden of severe disease.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

Get Swarajya in your inbox everyday. Subscribe here.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Comments ↓
Get Swarajya in your inbox everyday. Subscribe here.

Latest Articles

    Artboard 4Created with Sketch.